期刊文献+

2型糖尿病患者心电图QT间期的变化及卡托普利对其影响 被引量:1

Change of QT Interval Duration in Patients with Type 2 Diabetes and the Influence of Captopril on It
暂未订购
导出
摘要 目的 探讨 2型糖尿病患者心电图QT间期的变化及卡托普利对其影响。方法 对 189例糖尿病患者心电图QT间期进行测量 ,并按Bazett公式进行校正 ,取其校正的QT间期QTc与 12 0例正常人进行对照。给糖尿病患者卡托普利治疗 ,观察治疗 1、2、3、6个月后QTc间期的变化。结果 正常人QTc间期 ,男性 396± 1.7ms ,女性 418± 2 .3ms。糖尿病患者QTc ,男性 40 7± 1.9ms、女性 42 7± 2 .2ms。糖尿病患者卡托普利治疗 3、6个月后QTc间期缩短 ,分别为 :男性40 3± 2 .1ms、40 2± 1.6ms ,女性 413± 2 .3ms、412± 1.9ms。与治疗前相比具有显著性差异。结论  2型糖尿病患者QTc间期延长 ,卡托普利可使延长的QTc间期缩短。 Objective To investigate the change of QT interval duration in patients with type 2 diabetes and the influence of captopril on it.Method QT intervals in 189 patients with type 2 diabetes were measured and corrected for heart rate with Bazett's QT equation(QTc=QT/60/heart rate).Then QTc intervals were compared with those in 120 normal subjects.The patients with type 2 diabetes were given captopril,their QTc intervals were mearsured again after 1,2,3 and 6 months.Results QTc interval was 396±1.7ms in healthy men,418±2.3ms in healthy women,407±1.9ms in diabetic men and 427±2.2ms in diabetic women respectively.After 3 and 6 months of captopril treatment,QTc interval decreased to 403±2.1ms,402±1.6ms in diabetic men and 413±2.3ms,412±1.9ms in diabetic women respectively,which were significantly different from those before the treatment.Conclusions QTc interval prolongs in patients with type 2 diabetes.Captopril could shorten the increased QTc interval,which suggests that captopril may be useful in the prevention and treatment of the cadiovascular complications of diabetes.
机构地区 酒钢医院内科
出处 《现代诊断与治疗》 CAS 2003年第3期145-147,共3页 Modern Diagnosis and Treatment
关键词 2型糖尿病 心电图 QT间期 卡托普利 心血管并发症 血糖控制 Type 2 diabetes QTc interval Captopril
  • 相关文献

参考文献10

  • 1[1]De Bruyne MC,Hoes AW,Kors JA,et al.Prolonged QT interval predicts cardiac and all-cause mortality in the elderly.The Rotterdom Study[J].Eur Heart J,1999,20:278-284.
  • 2[2]Deker JM.The value of the heart-rate corrected QT-inteval for cardiovascular risk srratification[J].Eur Heart J,1999,20:250-251.
  • 3[3]Braunwald E,Zipes DP,Libby P.Heart disease[M].6th.Philadephia:Swunders company.2001.2133-2150.
  • 4[4]Karjalainen J,Reunanen A,Ristola P,et al.QT interval as a cardiac risk factor in a middle aged population[J].Heart,1997,77:543-548.
  • 5[5]Festa A,Agostino RD,Rautaharju P,et al.Relation of systemic blood pressure,left ventricular mass,insulin sensitivety,and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects[J].Am J Cardial,2000,86:1117-1122.
  • 6[6]Fauchier L,Blanche PM,Forhan A,et al.Association between heart rate-corrected QT interval and coronary risk factors in 2894 healthy subjects[J].Am J Cardial,2000,86:557-559.
  • 7[7]Brownlec M.Negative consequences of glycation[J].Metalism,2000,49:9-13.
  • 8[8]Williams SB,Cusco JA,Rodoly MA,et al.Impaired nitric oxide-mediated vasodilatiom in patients with non-insulin-dependent diabetes mellitus[J].J Am Coll Cadial,1996,27:567-574.
  • 9[9]Williams B.Angiotensin Ⅱ and the pathophysiology of cardiovascular remodeling[J].Am J Cardial,2001,87(suppl):10-17.
  • 10[10]Malik RA.Can diabetic neuropathy be prevented by angiotensin-converting enzyme in hibitors[J].Ann Med,2000,32:1-5.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部